ASPIRE
Asia Pacific Initiative on Reproduction
Aspire Logo
Asia Pacific Initiative on Reproduction
Bridging Reproductive Medicine Across Asia Pacific
Global Consensus Statement on Minimal Standards for Surrogacy
Live & Upcoming EduConnect

Webinar | Webseries | Podcast

ASPIRE Learning Hub
Educational Resources
EDU Portal
Upcoming Events
Nov2026
10th International Scientific Conference of FSSB
Dec2026
ASPIRE Session @ KSRM 2026 International Congress
Dec2026
Fertivision 2026 - 22nd Annual conference of Indian Fertility Society
May2027
The 16th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2027)
Latest News & Updates

We are delighted to announce that the Korean Society for Reproductive Medicine (KSRM) will host its first International Congress in Seoul from December 4 to 6, 2026.

 

Under the theme Advancing Reproductive Medicine: From Science to Soul, KSRM 2026 at Seoul Dragon City will bring together more than 30 globally renowned presenters for an outstanding scientific program featuring three plenary lectures, seven symposia and three joint sessions with ASPIRE, ASRM and the Japan Society for Reproductive Medicine (JSRM).

 

KSRM received an extraordinary number of excellent abstract submissions from 21 countries. The breadth and calibre of research to be presented at the Congress promises to offer attendees valuable opportunities to explore the latest advances in reproductive medicine. 

 

KSRM 2026 will provide a unique platform to connect with experts, exchange ideas, discuss pioneering research and build meaningful collaborations across borders.

 

We warmly invite colleagues from Asia and around the world to join us in Seoul to be part of this important milestone for KSRM.

ASPIRE News 17 Nov 2026
KOREA: Celebrating a new milestone: First International Congress of KSRM

We are delighted to announce that the Korean Society for Reproductive Medicine (KSRM) will host its first International Congress in Seoul from December 4 to 6, 2026.

0 1

Successful pregnancy depends on a single, decisive moment when the embryo must implant into a receptive endometrium. 

Yet for a significant number of couples undergoing fertility treatment, this step fails — sometimes once, sometimes repeatedly, and often without a clear explanation.

Repeated implantation failure (RIF) deserves particular attention because it sits at the intersection of so many unresolved questions in reproductive medicine. A single failed embryo transfer may simply reflect embryo-related chance events. 

But when implantation fails repeatedly despite good quality embryos, it signals that something in the maternal environment, the embryo-endometrium dialogue, or an underlying systemic condition may need deeper investigation. This matters for numerous reasons including emotional and financial burden, diagnostic complexity and a moving evidence base. 

In recent years, evidence for various RIF-related tests and interventions has been reviewed extensively, but findings often conflict underscoring the need for coordinated, evidence-based approaches rather than fragmented, trial-and-error management.

It requires personalised care and not a one-size-fits-all protocol.

By focusing specifically on repeated implantation failure, our SIG aims to move the field toward clearer diagnostic pathways and more reliable treatment algorithms ultimately shortening the journey to a successful pregnancy for couples across the region.

Building directly on the SIG's focus, ASPIRE hosted its 15th ASPIRE Masterclass: Recurrent Implantation Failure (RIF) – From Mechanisms to Management in October. It featured two days of evidence-based learning, clinical debate, and practical training in recurrent implantation failure from diagnosis to personalised management. 

The masterclass offered SIG members and the wider reproductive medicine community a timely, practical opportunity to deepen their expertise in exactly the area our SIG champions – turning the complex, multifactorial evidence around RIF into actionable, personalised patient care. 

Together, we can help close the gap between emerging evidence and everyday clinical practice.

 

ASPIRE News 14 Nov 2026
ENDOMETRIUM AND IMPLANTATION: Repeated Implantation Failure

Repeated implantation failure (RIF) deserves particular attention because it sits at the intersection of so many unresolved questions in reproductive medicine. A single failed embryo transfer may simply reflect embryo-related chance events. 

0 0

A landmark shift from industry self-regulation

Health ministers across Australia are working to unify IVF regulation, which is currently spread across about 30 State and Territory laws.

As part of this process, a rapid review has recommended an accreditation shift from industry self-regulation to the Australian Commission on Safety and Quality in Health Care. 

This builds on a reform blueprint from the Fertility Society of Australia and New Zealand (FSANZ), led by former Federal Health Minister Greg Hunt.

The FSANZ Annual Conference at the National Convention Centre in Canberra in August addressed the theme ART Regulation, Innovation and Trust in Fertility Care. 

It brought together clinicians, embryologists, researchers and policy makers for three days of excellent presentations and policy discussion much of tied to the regulatory reforms referred to above. 

Dr Michele Kwik, Country Representative

ASPIRE News 14 Nov 2026
AUSTRALIA: A landmark shift from industry self-regulation

Health ministers across Australia are working to unify IVF regulation, which is currently spread across about 30 State and Territory laws.

0 0
Read All News & Updates

Share this News